Republican push fuels rapid rise of antivaccine laws in US states

A new analysis led by Boston University School of Public Health researchers finds that anti-vaccine attitudes, once largely expressed as individual beliefs and public debate, have increasingly materialized as state-level legislation in the United States. The study focuses on how proposed bills changed after the COVID-19 pandemic, when vaccine hesitancy spread alongside misinformation and growing distrust in scientific institutions.

Using data from the State Vaccine Policy Project (SVPP), the team systematically categorized 1,513 vaccine-related bills introduced in state legislatures between 2019 and 2023. The investigation is observational in design and examines legislative intent by classifying proposals as antivaccine, provaccine, or mixed, allowing researchers to compare the partisan distribution of policy signals across time.

The results show a substantial legislative shift beginning in the early pandemic period. Proposed antivaccine measures—such as bills aiming to reduce vaccine access, weaken vaccination requirements, and expand exemptions—rose sharply during 2021–2023. In several legislative cycles, the number of antivaccine proposals exceeded the number of bills intended to strengthen vaccination policies.

The study also reports that antivaccine proposals accounted for at least 40% of bills introduced in each full legislative cycle after the pandemic began. Partisan polarization was central: Republican lawmakers sponsored 86% of antivaccine bills, while Democrats introduced 54% of provaccine bills supporting greater access, funding, and promotion of immunization.

Importantly, the work distinguishes between proposals and enacted policy. Even though many antivaccine bills do not pass, 24% of antivaccine legislation during the period was advanced enough to become law. Enacted measures included expanded religious or personal belief exemptions for childcare and school immunizations, and restrictions on employer vaccination mandates in certain settings.

The authors argue that weakening vaccine protections can have population-level consequences that extend beyond state borders. Low coverage in one region can accelerate outbreaks elsewhere, an effect consistent with historical patterns of infectious disease spread and reinforced by current examples such as measles resurgence.

The study further contextualizes the findings within electoral dynamics. As the U.S. approaches the November midterm elections, the authors note that who voters elect could shape vaccine policy trajectories for years, potentially entrenching legislative environments hostile to immunization.

Finally, the researchers emphasize that vaccine communication strategies must account for the multifaceted drivers of trust and hesitancy. They call for investments in evidence-based message targeting and messenger selection, suggesting that public health officials may not always be the most effective conveyors of vaccine information.